Zobrazeno 11 - 20
of 28
pro vyhledávání: '"Nathalie M. Delfos"'
Autor:
Masja Leendertse, Nathalie M. Delfos, Eva B D Molendijk, Soufian Meziyerh, Mark G. J. de Boer, Emile F. Schippers, Olaf M. Dekkers, Leo G. Visser, Alexandra T. Bernards, Merel M C Lambregts
Publikováno v:
International Journal of Clinical Practice, 74(11). WILEY
International Journal of Clinical Practice
International Journal of Clinical Practice
Objective A cornerstone in the management of Staphylococcus aureus bacteraemia (SAB) is the differentiation between a complicated and an uncomplicated SAB course. The ability to early and accurately identify patients with ‐ and without ‐ complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59016d9c155033c6c7498a8457cc0957
http://hdl.handle.net/1887/3181896
http://hdl.handle.net/1887/3181896
Autor:
Janneke E. Stalenhoef, Darius Cameron Wilson, Cees van Nieuwkoop, Tanny J. K. van der Reijden, Ted Koster, Eliane M. S. Leyten, Hans C. Ablij, Jaap T. van Dissel, Nathalie M Delfos, Johannes Jan Willem van 't Wout, Willize E. van der Starre
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
A reduction in duration of antibiotic therapy is crucial in minimizing the development of antimicrobial resistance, drug-related side effects and health care costs. The minimal effective duration of antimicrobial therapy for febrile urinary tract inf
Autor:
Nathalie M. Delfos, Anne M.C. Witte, Jonathan W. Uzorka, Sandra M. Arend, Dick van Soolingen, Henk Scheper
Publikováno v:
European Respiratory Journal
European Respiratory Journal, 52(2)
European Respiratory Journal, 52(2)
Development of tuberculosis after a borderline QuantiFERON result during screening before TNF-α antagonist therapyhttp://ow.ly/zW1u30kw2Qv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c69baabcf6b12a5336cbff93bb80690
https://hdl.handle.net/1887/87143
https://hdl.handle.net/1887/87143
Autor:
Cees van Nieuwkoop, Nathalie M Delfos, Willize E. van der Starre, Janneke E. Stalenhoef, Ted Koster, Albert M Vollaard, Jaap T. van Dissel, Hans C. Ablij, Ewout W. Steyerberg, Eliane M. S. Leyten, Jan W van't Wout
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-9 (2017)
BMC Infectious Diseases, 17
BMC Infectious Diseases
BMC Infectious Diseases, 17:400. BioMed Central Ltd.
BMC Infectious Diseases, 17
BMC Infectious Diseases
BMC Infectious Diseases, 17:400. BioMed Central Ltd.
Background There is a lack of severity assessment tools to identify adults presenting with febrile urinary tract infection (FUTI) at risk for complicated outcome and guide admission policy. We aimed to validate the Prediction Rule for Admission polic
Autor:
N. J. M. Aarts, Bart Mertens, G. H. Wattel-Louis, J. W. van't Wout, J. T. Van Dissel, Hans C. Ablij, B. P. C. Hoppe, Ted Koster, Eliane M. S. Leyten, C. van Nieuwkoop, Henk W. Elzevier, Nathalie M Delfos, Tobias Bonten
Publikováno v:
Clinical Infectious Diseases
Background Radiologic evaluation of adults with febrile urinary tract infection (UTI) is frequently performed to exclude urological disorders. This study aims to develop a clinical rule predicting need for radiologic imaging. Methods We conducted a p
Autor:
Janneke E. Stalenhoef, C. van Nieuwkoop, Albert M Vollaard, Nathalie M Delfos, Ted Koster, J. W. Van't Wout, Eliane M. S. Leyten, W. E. Van Der Starre, Hans C. Ablij, J. T. Van Dissel
Publikováno v:
Open Forum Infectious Diseases. 2
A total of 370 patients were included, 237 in the control period and 133 in the intervention period. Use of PRACTICE significantly reduced the primary hospitalization rate (from 92%, in the control group to 72%, in the intervention group, p
Autor:
Ida C. Spelt, Hans C. Ablij, A M Vollaard, J. T. Van Dissel, C van Nieuwkoop, S M Zunder, Eliane M. S. Leyten, J. W. Van't Wout, Ted Koster, W. E. Van Der Starre, Nathalie M Delfos, J W Blom, J E Stalenhoef
Publikováno v:
Clinical Microbiology and Infection, 20(10), 1048-1054
Bacterial infections such as febrile urinary tract infection (fUTI) may run a complicated course that is difficult to foretell on clinical evaluation only. Because the conventional biomarkers erythrocyte sedimentation rate (ESR), leucocyte count, C-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0da1592ec97c565b67004434feefbf3b
http://hdl.handle.net/1887/104210
http://hdl.handle.net/1887/104210
Autor:
Hans C. Ablij, Eliane M. S. Leyten, Cees van Nieuwkoop, Ted Koster, Ida C. Spelt, Willize E. van der Starre, Jeanet W. Blom, Albert M Vollaard, Hanneke Borgdorff, Jan W. van ’t Wout, Jaap T. van Dissel, Nathalie M Delfos
Publikováno v:
Diabetes Care
Diabetes Care, 36(12), E193-E194
Diabetes Care, 36(12), E193-E194
Diabetes is considered a risk factor for acquisition of febrile urinary tract infection (UTI) (1,2), but there is a lack of information on the association of diabetes with the subsequent course of disease and its outcome. We performed a prospective o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ca352e8553e9a1fe67d84a69407936b
https://doi.org/10.2337/dc13-0903
https://doi.org/10.2337/dc13-0903
Autor:
Eliane M. S. Leyten, Jan W van't Wout, G Hanke Wattel-Louis, Hans C. Ablij, Cees van Nieuwkoop, Nathalie M Delfos, Jeanet W. Blom, Geert H. Groeneveld, Sunita Paltansing, Willize E. van der Starre, Jaap T. van Dissel, Ted Koster, Martin J Becker
Publikováno v:
Journal of Antimicrobial Chemotherapy, 66(3), 650-656
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy
Objectives To assess risk factors for fluoroquinolone resistance in community-onset febrile Escherichia coli urinary tract infection (UTI). Methods A nested case-control study within a cohort of consecutive adults with febrile UTI presenting at prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70774a8b9a5d10ccf0661c11d614a37
https://hdl.handle.net/1887/118930
https://hdl.handle.net/1887/118930
Autor:
Jaap T. van Dissel, Henk W. Elzevier, Nathalie M Delfos, Eliane M. S. Leyten, Jan Pander, Willem J J Assendelft, G Hanke Wattel-Louis, Jeanet W. Blom, Hans C. Ablij, Cees van Nieuwkoop, Ida C. Spelt, Ted Koster, Ed J. Kuijper, Jan W van't Wout
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 9, Iss 1, p 131 (2009)
BMC Infectious Diseases, Vol 9, Iss 1, p 131 (2009)
Background Current guidelines on the management of urinary tract infection recommend treating febrile urinary tract infection or acute pyelonephritis with antimicrobials for at least 14 days. Few randomized trials showed the effectiveness of treatmen